arrow
K

Kenneth Aldape

national institutes of health
H指数:141
被引数:9.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Divergent genomic evolution in astrocytomas and oligodendrogliomas

星形胶质瘤和少突胶质瘤的基因组趋异进化

Nature
IF48.5
2026-10-140
OAAI
High-grade astrocytoma with piloid features: a clinical and genomic analysis of prognostic factors using a large cohort

伴毛细胞样特征的间变性星形细胞瘤:利用大型队列进行预后因素的临床和基因组学分析

2026-09-160
PRE
Complementary use of the DNA methylation-based tumor classification by the Bethesda v3 classifier in routine diagnostics: evaluation in a series of 516 cases

Bethesda v3分类器在常规诊断中对基于DNA甲基化的肿瘤分类的补充性应用:对516例病例的评估

2026-09-150
PRE
The Spatiotemporal Evolution of Radiation Resistance in Glioblastoma

胶质母细胞瘤中辐射抵抗的空间-时间演变

2026-09-150
PRE
Intercellular adhesion molecule 1 links glioblastoma biology to a scalable prognostic model integrating clinical, imaging, and molecular features

细胞间黏附分子1将胶质母细胞瘤生物学与整合临床、影像和分子特征的规模化预后模型联系起来

2026-07-110
OA
Right medial temporal lobe mass in a 25-year-old male

右侧 medial temporal lobe mass,25岁男性

2026-03-160
OAAI
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma

基于DNA甲基化建模的头颅脑膜瘤临床管理框架

2025-11-190
OA
Assessment of Molecular Tools in Pediatric, Adolescent and Young Adult Meningioma Highlights Unique Biology and Underscores the Need for Lifespan Precision in Neuro-Oncology

分子工具在儿科、青少年和青年成人脑膜瘤中的评估突出了其独特的生物学特性,并强调了神经肿瘤学中全生命周期精准化的必要性。

2025-11-010
OAAI
MOLECULAR ANALYSIS OF OUTCOMES IN ECOG-ACRIN E3F05: PHASE III STUDY OF RADIATION THERAPY WITH OR WITHOUT TEMOZOLOMIDE FOR SYMPTOMATIC OR PROGRESSIVE LOW-GRADE GLIOMAS

分子分析ECOG-ACRIN E3F05研究结局:针对症状性或进展性低级别胶质瘤的放射治疗联合或不联合替莫唑胺的III期研究

2025-11-010
OAAI
TERT EXPRESSION IN MENINGIOMAS PREDICTS PROGRESSION-FREE SURVIVAL INDEPENDENT OF TERT PROMOTER MUTATION

TERT在脑膜瘤中的表达可独立于TERT启动子突变预测无进展生存期

2025-11-010
OAAI
PROGNOSTIC AND PREDICTIVE MARKERS FOR OUTCOME IN PATIENTS WITH IDHMT TUMORS TREATED IN THE EORTC CATNON TRIAL ON ADJUVANT AND/OR CONCURRENT TEMOZOLOMIDE IN ANAPLASTIC ASTROCYTOMA

IDHMT肿瘤患者在接受EORTC CATNON试验中辅助和/或同步替莫唑胺治疗的间变性星形细胞瘤中的预后和预测性生物标志物

2025-11-010
OAAI
THE MOLECULAR LANDSCAPE AND ITS PROGNOSTIC IMPLICATIONS IN ADULT PAPILLARY TUMORS OF THE PINEAL REGION - A MULTICENTER YOUNGNOA INVESTIGATION

松果体区成人乳头状肿瘤的分子景观及其预后意义——一项多中心YoungNoa研究

2025-11-010
PRE
SLC44A1::PRKCA fusion-positive glioneuronal tumor without histological and epigenetic features of papillary glioneuronal tumor

SLC44A1::PRKCA融合阳性的胶质神经元肿瘤,无乳头状胶质神经元肿瘤的病理学及表观遗传学特征

2025-11-010
PRE
CERN 09-02: A PHASE 2 TRIAL OF CARBOPLATIN AND BEVACIZUMAB FOR RECURRENT ADULT EPENDYMOMA

CERN 09-02:一项关于卡铂和贝伐珠单抗治疗复发性成人室管膜瘤的II期临床试验

2025-11-010
OAAI